# COVID-19 Antibody Responses In Cystic Fibrosis

> **NCT04863573** · — · UNKNOWN · sponsor: **Queen's University, Belfast** · enrollment: 1000 (estimated)

## Conditions studied

- Covid19
- Cystic Fibrosis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04863573
- **Lead sponsor:** Queen's University, Belfast
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-11-19
- **Primary completion:** 2024-05
- **Final completion:** 2024-05
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2022-02-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04863573

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04863573, "COVID-19 Antibody Responses In Cystic Fibrosis". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04863573. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*